C
ancer researchers worldwide are increasingly focusing on the link between obesity and cancer. epi demiological studies over the past 30 years have consistently shown that diabetics and obese people have a higher risk of getting cancer than lean healthy people, and when they do get it their risk of dying from it is greater.
But not all fat tissue is the same. Now researchers are focusing on how two types of fat tissue-white adipose tissue (WAt) and brown adipose tissue (BAt)-may affect cancer growth.
White Adipose Tissue once considered a mere energy storage depot, adipose tissue has revealed itself to be more than just an innocent bystander in promoting chronic disease. White adipose tissue secretes adipokines that include hor mones such as insulin and leptin, cytokines and growth factors that may stimulate or inhibit cell growth and cause systemic inflammation. For example, insulin and insulinlike growth factor (IGF), a related hormone, play a role in fueling a range of cancers including breast, prostate, and blad der. Because obese people have more WAt than healthy people, they also have higher levels of certain circulating adipokines. Studies in animal models have shown that tumors can take advantage of adipokines. While systemi cally circulating adipokines may be important, studies also point to neighboring adipose tis sue as a potential contributor.
"the tumor microenviron ment is very important and understudied," explained mikhail Kolonin, Ph.D., associate professor at the Center for Stem Cell and regenerative medicine at the university of texas health Science Center in houston. In some tumors, the majority of cells are not malignant, he said, they are rather infil trating stromal and vascular cells of mixed origin. the problem for researchers has been that in humans, there is no sure way to identify the cells' origins. Some research groups have been able to show in animal models and cell culture that mesenchymal stem cells (mSCs) appear to be recruited by tumors in response to inflammatory and hypoxia signals. At tumor sites, they engage in tissue remodeling aimed at normal organ repair. While bone marrow is certainly a source of these progenitor cells, three years ago Kolonin came up with a hypothesis that adipose tissue may also contribute to can cers associated with obesity.
"most of the focus has been on bone marrow as a source of progenitor cells," said Francesco Bertolini, m.D., Ph.D., at the european Institute of oncology in milan, Italy who is collaborating with Kolonin. "But we think that adipose tissue is an even richer source."
In fact, when compared to bone mar row, there are more than 250 times more CD45CD34+ progenitor cells (progenitors with both mesenchymal and endothelial dif ferentiation potential) in 1 gram of fat when compared to 1 gram of aspirated bone mar row [Cancer res. 2012; 72:32534] 
N E W S
Stephan herzig, Ph.D, head of the Joint research Division of molecular metabolic Control Joint research Division of molecular metabolic Control at the German Cancer research Center, the Center for molecular Biology, and the university hospital in heidelberg, Germany, had been interested in the relationship between BAt tissue and metabolic disease, but then he found himself wondering whether adipokines-peptides secreted by adipose tissue-might play an indirect role in either promoting or inhibit ing cancer progression. But not just any adi pokines, only those specifically secreted by BAt.
In January of this year, herzig was awarded a €1 million grant by the Deutsche Forschungsgemeinschaft, Germany's pri mary science funding agency, to study the role BAt may play in cancer progression. "It's a very interesting and open question," said herzig. Brown adipose cells con sume a lot of glucose. In fact, that is how researchers discovered that adult humans store BAt in the first place. For years radiologists who were screening people for cancer using a glucose tracer noticed another type of tissue light up. When the tissue was biopsied, they determined it was BAt.
Several studies suggest that BAt is more sensitive to insulin than WAt, and consequently consumes glucose at a higher rate. It's also clear that obese people have less active BAt than thin people. Given that insulin and insulinlike growth fac tor have been found to fuel tumors, with his grant, herzig plans to study whether having more or less BAt would affect a person's overall systemic insulin sensitivity and thereby have an indirect influence on tumor progression.
BRITE: Another Type of Fat
Since the discovery of BAt in humans, researchers have also discovered another population of fat cells found within WAt that function like BAt. Some researchers refer to this tissue as BrIte (brown into white). BrIte cells appear de novo under certain conditions in white adipose tissue stores. About two years ago, herzig and his colleagues showed that the CoX2 enzyme, a key enzyme in the production of prosta glandin, was important in creating BrIte cells in WAt. When the enzyme was inac tivated in mice, they lost the ability to con vert WAt into BrIte [Science. 2010 may 28; 328 (5982):115861] . "this was sur prising," herzig said. "Prostaglandins have been looked at for 50 years and have been implicated in inflammatory conditions. this was a new function."
Further study showed that manipulating the prostaglandin pathway, by way of affect ing the conversion of WAt into BrIte, had an impact on overall energy regulation. mice with the CoX2 prostaglandin path way always active, and consequently with high levels of circulating prostaglandins, were protected against diet induced obesity. these mice had better insulin sensitivity and better glucose regulation, herzig said. Since the CoX2 pathway is sometimes aberrant in cancer, manipulating the pathway might change the energy balance in cancer patients, particularly in those with cachexia, the wast ing syndrome that afflicts up to 50% of can cer patients and can be fatal, herzig reasoned.
Since both BAt and BrIte cells break down fat tissue to generate heat, and thin people appear to have more active BAt than obese people, many researchers are studying whether the balance of BAt and WAt tissues in people influences obesity and diabetes.
Indeed pharmaceutical companies are deeply interested in this issue because stud ies show that when activated, typically by cold exposure or certain medications, BAt can increase a person's metabolic rate-by as much as 1.8 times a person's resting rate, according to a recent paper published in the Journal of Clinical Investigation by André Carpentier and colleagues at the université de Sherbrooke in ouébec Canada [J Clin Invest. 2012; 122 (2):545-552] . to put that number in perspective, walking increases a person's metabolic rate by 2 to 3 times, said Carpentier. the study participants' elevated metabolic rate amounted to roughly 250 extra calories burned after 3 hours of cold exposure, "which isn't insignificant," Carpentier said.
research on BAt may also affect can cer indirectly. If activating BAt or BrIte tissue can help people lose weight, it may cut cancer rates, since obesity can double a person's chances of getting cancer. "you would hypothesize that anything that can help people lose weight would reduce their risk of cancer," Lazar said.
At the very least, the research will help to deepen the understanding of the function of different adipose tissues, and how they potentially influence chronic disease in gen eral, said Carpentier. "It's not everyday that researchers rediscover a potentially novel mechanism for metabolism in humans."
